Solara Active Pharma Sciences Limited (NSEI: SOLARA)
Health Care · Pharmaceuticals · IN
Rs616.90
+20.42% today · -1.5% 1Y
Solara Active Pharma Sciences Limited (NSEI: SOLARA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $310.60M and employs 2,156 people.
Over the last twelve months the share price has lost 1.5%, trading between 422.00 and 712.00.
Tweenvest scores Solara Active Pharma Sciences Limited across four factors: quality 54/100, value 52/100, growth 0/100. Its strongest factor is quality.
SOLARA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $310.60M
- Revenue (TTM)
- $151.39M
- P/E
- —
- EPS
- -0.36
- Dividend yield
- —
- Beta (5Y)
- 0.89
- 52-week high
- Rs712.00
- 52-week low
- Rs422.00
- Avg volume (3M)
- —
- Shares outstanding
- 48.17M
- Employees
- 2,156
- Next earnings
- —
About Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited is an Indian-based pharmaceutical company primarily involved in the comprehensive development, production, and global trade of active pharmaceutical ingredients (APIs). Their activities span the manufacturing, processing, sale, import, and export of these essential drug components. The company's extensive product range includes APIs designed for a wide spectrum of therapeutic applications, such as anesthetics, antibiotics, antivirals, cardiovascular agents, central nervous system treatments, anti-inflammatory drugs, and treatments for metabolic disorders like type-II diabetes, among numerous other specialized categories. Beyond its core product offerings, Solara also delivers specialized contract research and manufacturing services (CRAMS) for APIs. These services encompass custom development and manufacturing, analytical support, impurity synthesis, and comprehensive regulatory assistance. The company maintains a significant international presence, exporting its products and conducting operations across diverse global regions, including the Asia Pacific, Europe, North America, and South America. Headquartered in Chennai, India, Solara Active Pharma Sciences Limited was established in 2017. Initially known as SSL Pharma Sciences Limited, the company adopted its current name in March of the same year.
- ISIN
- INE624Z01016
- Founded
- 2017
- Listed since
- Jun 27, 2018
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.